<DOC>
	<DOC>NCT02004613</DOC>
	<brief_summary>Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery</brief_summary>
	<brief_title>Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery</brief_title>
	<detailed_description>The investigator goal is to evaluate the effects of intraoperative and postoperative dexmedetomidine sedation (versus placebo after cardiac surgery.</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1. 1885 years old; 2. Scheduled for cardiac surgery with bypass (CABG, valve, or combined); 3. Able to provide a written informed consent; 4. Hemodynamically stable (heart rate&gt;= 55). 1. Sick sinus syndrome or WolffParkinsonWhite syndrome 2. Atrioventricular block 3. Hypersensitivity or known allergy to dexmedetomidine 4. Hepatic disease, e.g. twice the normal level of liver enzymes 5. AF within 1 preoperative month; 6. Permanent pacemaker; 7. Use of amiodarone or dexmedetomidine within the last 30 days; 8. Patients with an ejection fraction under 30% or who had severe heart failure 9. Myocardial infarction in the previ¬ous 7 days; 10. Body mass index =&lt; 40 (BMI= mass (kg) / height (m)2); 11. Those tak¬ing clonidine within last 48 hours.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>